Other
Defocus Curve
Defocus Curve is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
NCT06041139
completed
Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients
NCT06064916
completed
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
NCT05226884
Clinical Trials (3)
Showing 3 of 3 trials
NCT06041139
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
NCT06064916
Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients
NCT05226884
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3